Alexza Pharmaceuticals' Adasuve approved by FDA

theflyonthewall.com

Alexza Pharmaceuticals announced that the FDA approved Adasuve Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Adasuve combines Alexza's proprietary Staccato delivery system with the antipsychotic drug, loxapine.

Rates

View Comments (0)